Maini, A;
O'Brien, A;
(2017)
Be vigilant for non-alcoholic fatty liver disease in primary care.
Practitioner
, 261
(1806)
pp. 19-22.
![[thumbnail of O'Brien_AM revised2017 (3).pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/text.png) |
Text
O'Brien_AM revised2017 (3).pdf - Accepted Version Access restricted to UCL open access staff Download (502kB) |
Abstract
Non-alcoholic fatty liver disease (NAFLD) is now the most common cause of chronic liver disease in the Western world. Between 10 and 30% of NAFLD patients will develop non-alcoholic steatohepatitis (NASH) with a risk of progression to cirrhosis. Of those with NASH and fibrosis at presentation, studies have suggested that approximately 21% of patients will have some regression of fibrosis while 38% of patients will progress over five years’ follow-up.
| Type: | Article |
|---|---|
| Title: | Be vigilant for non-alcoholic fatty liver disease in primary care |
| Publisher version: | https://www.thepractitioner.co.uk/Symposium/Gastro... |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inst for Liver and Digestive Hlth |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10040509 |
Archive Staff Only
 |
View Item |
